Sarah Spencer
Investor Relations Kontakt bei VOR BIOPHARMA INC.
Aktive Positionen von Sarah Spencer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VOR BIOPHARMA INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - |
Karriereverlauf von Sarah Spencer
Ehemalige bekannte Positionen von Sarah Spencer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 01.04.2019 | 01.04.2021 |
| GSK PLC | Public Communications Contact | - | - |
Ausbildung von Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
Operativ
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Investor Relations Contact | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Sarah Spencer
- Erfahrung
